CTRI/2025/03/081550尚未招募4 期
Comparative study to evaluate the efficacy of Sudarshan ghanvati and Aarogyavardhini Vati in disintegration of pathogenesis of non-alcoholic fatty liver disease- A Randomized control trial
Ch Brahm Prakash Ayurved Charak Sansthan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月14日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- 1. USG - Whole Abdomen
研究概览
简要总结
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease worldwide. NAFLD is a spectrum of the disease characterized by hepatic steatosis when no other causes for secondary hepatic fat accumulation (e.g., excessive alcohol consumption) can be identified.
Total 60 patients will be enrolled in two groups of Sudarshan ghanvati and Aarogyavardhini vati and will be treated for 45 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 21.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of either gender between age of 21 to 65 years.
- •Diagnosed patients of NAFLD grade 1 and grade
- •Patients willing to provide consent to participate in the study.
排除标准
- •Pregnant women and lactating mothers.
- •Patients with serious cardiac or renal disorders.
- •Drug induced serious illness.
- •Patients suffering from Cirrhosis of liver.
结局指标
主要结局
1. USG - Whole Abdomen
时间窗: day0,day45
次要结局
- secondary Outcome
研究者
Dr Umesh Kumar Sapra
Chaudhary Brahm Prakash Ayurved Charak Sansthan
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
Clinical experiment to find the effect of bloodletting with daily Purgation therapy for the treatment of liver disease.CTRI/2025/03/082679Parul Ayurved Hospital30
已完成
2 期
A Study on Mandurathi Kudineer in the management of Kaleeral Noi (Non-Alcoholic Fatty Liver Disease).CTRI/2024/06/068735National Institute of Siddha20
招募中
Phase 3 4
Treatment of non alcoholic fatty liver disease in adults using Sesame extract(S3 complex)CTRI/2025/08/092526M/s.Ingex Botanicals Pvt Ltd60
尚未招募
2/3 期
A clinical trial to study the effect of two medicines Vaishwanara Choornam and aqueous extract of Drakshadi Kashayam in patients with Non-Alcoholic Fatty Liver DiseaseCTRI/2024/08/072611NIDHISH NAIR20
尚未招募
3 期
Hepatoprotective Activity of Ayurvedic drug formulationsCTRI/2025/01/079324BVG life Sciences Limited90